Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
5
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
5
×
san diego top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer immunotherapy
clinical trials
startups
venture capital
biogen
deals
deerfield management
drug development
eli lilly
europe blog main
What
ipo
5
×
bio
roundup
companies
covid
life
medicines
new
plans
public
science
sciences
week
acquisitions
activity
advance
announced
approvals
arena’s
biogen
biology
biotechs
bounty
ceo
cig
clamped
club
collabs
comeback
company
continued
corner
crop
cytokine
daniel
deal
deals
delays
delivered
developing
Language
unset
Current search:
cancer
×
ipo
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M